A novel FGF-1 receptor tyrosine kinase inhibitor which has been shown to effectively suppress constitutive phosphorylation of the FGF-1 receptor in human ovarian carcinoma cells.
Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.